DavidAgus_2009P 1 DavidAgus_2009P 1005.04 1008.15 <o,f0,female> so this is a(2) woman {UM} forty six years(2) old <sil> (DavidAgus_2009P-1005.04-1008.15-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 1008.39 1018.03 <o,f0,female> who had {NOISE} recurrent <sil> lung cancer <sil> it was in her <sil> brain <sil> in her {UM} lungs <sil> in her liver {SMACK} she had gotten <sil> carboplatin taxol <sil> carboplatin {SMACK} <sil> (DavidAgus_2009P-1008.39-1018.03-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 1021.30 1029.61 <o,f0,female> every drug {UH} we have(2) {BREATH} she had {COUGH} gotten <sil> and that {UH} disease continued <sil> to grow {BREATH} she had {COUGH} three kids <sil> under(2) the(2) age of twelve <sil> (DavidAgus_2009P-1021.30-1029.61-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 1030.65 1038.20 <o,f0,female> and(2) this is her cat scan and so what this is is {BREATH} we're taking a cross section of her body here <sil> and you can(2) see {NOISE} in {UH} the(2) middle there is her heart <sil> (DavidAgus_2009P-1030.65-1038.20-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 103.61 114.30 <o,f0,female> and tell you {COUGH} where i think it's going(2) <sil> where {UH} a new approach {UM} that we hope {UH} to {NOISE} push forward {BREATH} in terms of treating {SMACK} cancer {BREATH} because(2) this is wrong <sil> (DavidAgus_2009P-103.61-114.30-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1038.47 1049.78 <o,f0,female> and to(2) the {UH} side of her heart on the left there {NOISE} is this large {NOISE} tumor <sil> that will(2) invade {SMACK} and will(2) kill her <sil> untreated {NOISE} in a matter of weeks <sil> she goes on a {UH} pill a day <sil> (DavidAgus_2009P-1038.47-1049.78-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 1050.71 1060.61 <o,f0,female> that(2) {COUGH} targets <sil> a(2) pathway <sil> and again {UH} i'm not sure if this pathway was in the(2) system <sil> in the(2) cancer but it targeted a pathway {SMACK} and a month later pow (DavidAgus_2009P-1050.71-1060.61-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 1064.06 1073.95 <o,f0,female> six months later it's still gone <sil> that cancer recurred and(2) she passed away three years later <sil> from lung {NOISE} cancer <sil> but she got <sil> three years <sil> (DavidAgus_2009P-1064.06-1073.95-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 1074.60 1082.29 <o,f0,female> from a drug <sil> whose symptoms predominately(2) were(2) acne <sil> that's about it {BREATH} so {UH} the problem is {NOISE} that {SMACK} the <sil> (DavidAgus_2009P-1074.60-1082.29-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 1092.24 1098.42 <o,f0,female> would you want your(2) mother your brother your(2) sister to get {COUGH} a placebo if they had advanced lung cancer and had weeks to live(2) <sil> (DavidAgus_2009P-1092.24-1098.42-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1108.11 1116.88 <o,f0,female> and {NOISE} the drug went {COUGH} to(2) the {UH} fda {UH} and <sil> the {UM} fda {NOISE} said without a placebo <sil> how do i know(2) <sil> patients actually(4) {SMACK} benefited from the drug {UH} (DavidAgus_2009P-1108.11-1116.88-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1118.14 1123.47 <o,f0,female> so the morning the {UH} fda {NOISE} was going(2) to(2) meet {SMACK} this was the {UH} editorial in the wall street journal <sil> (DavidAgus_2009P-1118.14-1123.47-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1125.24 1135.28 <o,f0,female> {NOISE} and(2) {COUGH} so what(2) do you know(2) <sil> that drug <sil> was approved {COUGH} the {UM} amazing thing is another company <sil> did the right <sil> scientific trial(2) <sil> where they gave half {BREATH} placebo <sil> (DavidAgus_2009P-1125.24-1135.28-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1135.49 1143.34 <o,f0,female> and half the drug {BREATH} and we learned something important there what's(2) interesting is they did it in south america and canada {BREATH} where it 's(2) {NOISE} more ethical(2) to give placebos {SMACK} (DavidAgus_2009P-1135.49-1143.34-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1144.01 1155.24 <o,f0,female> they had to {COUGH} give it <sil> also in the(2) u s to(2) get approval so i think there were(2) three u s <sil> patients in upstate new york who were(2) part of the trial(2) {BREATH} but they <sil> did that and what they found <sil> is that seventy percent of the non responders <sil> (DavidAgus_2009P-1144.01-1155.24-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1156.01 1169.20 <o,f0,female> lived(2) much {SMACK} longer {COUGH} and did {SMACK} better <sil> than <sil> people who got placebo {BREATH} so {UH} it challenged <sil> everything we knew in cancer {COUGH} is that you don't need to get a response {BREATH} you don't(2) need to shrink {COUGH} the disease {NOISE} if we slow the disease <sil> (DavidAgus_2009P-1156.01-1169.20-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 116.46 123.32 <o,f0,female> so {NOISE} what is cancer first of all <sil> well {UH} if {COUGH} one has {SMACK} a mass {NOISE} or an <sil> abnormal blood value you go to a doctor <sil> (DavidAgus_2009P-116.46-123.32-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1169.64 1176.90 <o,f0,female> we may have(2) more of a benefit {BREATH} on(2) <sil> patient {SMACK} survival(2) <sil> patient <sil> outcome how they feel <sil> than if we shrink {SMACK} the disease <sil> (DavidAgus_2009P-1169.64-1176.90-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1177.20 1188.31 <o,f0,female> the problem is {NOISE} that if {UM} i'm this <sil> doc <sil> and i get {BREATH} your(2) cat scan today and you've got a(2) <sil> two centimeter {BREATH} mass in your(2) liver <sil> and you come back to me in three months and it's three centimeters <sil> did that drug help you or not (DavidAgus_2009P-1177.20-1188.31-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1189.39 1202.97 <o,f0,female> how do i know(2) <sil> would it have been(2) ten centimeters <sil> or am i giving you a drug <sil> with no {COUGH} benefit <sil> and significant(2) cost {BREATH} so {UH} it's a fundamental problem <sil> and again <sil> that's <sil> where these new technologies <sil> (DavidAgus_2009P-1189.39-1202.97-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1203.49 1211.08 <o,f0,female> can come in <sil> and so the goal obviously is {UH} that you go into your(2) doctor 's(3) office {BREATH} well {UH} the(2) ultimate goal is that {COUGH} you prevent disease <sil> (DavidAgus_2009P-1203.49-1211.08-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1211.66 1220.58 <o,f0,female> right the(2) ultimate goal is {NOISE} that <sil> you prevent <sil> any of these things from happening(2) <sil> that is the most effective <sil> cost(2) effective <sil> best way we can(2) do things today <sil> (DavidAgus_2009P-1211.66-1220.58-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 123.62 130.93 <o,f0,female> they {NOISE} stick a needle in <sil> they way we make the diagnosis today <sil> is by pattern recognition(2) <sil> does it look normal (DavidAgus_2009P-123.62-130.93-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1243.36 1254.18 <o,f0,female> there are eleven orders of magnitude {SMACK} difference between the high abundant {BREATH} and the low abundant proteins {BREATH} so there's no technology in the world that can span eleven orders of magnitude <sil> (DavidAgus_2009P-1243.36-1254.18-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1254.73 1262.90 <o,f0,female> and(2) so {NOISE} a lot of what has {COUGH} been(2) done {UH} with danny {SMACK} hillis <sil> and {NOISE} others {BREATH} is to {SMACK} try {UH} to {UM} bring in {NOISE} engineering principles <sil> try {NOISE} <sil> (DavidAgus_2009P-1254.73-1262.90-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1274.29 1282.51 <o,f0,female> the(2) exiting things that is starting to happen now {UH} is that people from those fields {NOISE} are(2) coming in {BREATH} yesterday the national <sil> cancer institute announced a new program <sil> (DavidAgus_2009P-1274.29-1282.51-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1282.84 1296.67 <o,f0,female> {UH} called {NOISE} the physical sciences and oncology {BREATH} where physicists <sil> mathematicians {BREATH} are brought in to(2) think about cancer people who {NOISE} never approached it before {SMACK} danny and i got sixteen million dollars they announced yesterday <sil> to try to attach this problem <sil> (DavidAgus_2009P-1282.84-1296.67-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1297.16 1310.52 <o,f0,female> a whole new approach {SMACK} instead of {UH} giving high doses of chemotherapy {BREATH} by {UH} different mechanisms {SMACK} to try to bring <sil> technology {SMACK} to(2) get a {COUGH} picture <sil> of what's {COUGH} actually(4) happening <sil> in the body <sil> so <sil> (DavidAgus_2009P-1297.16-1310.52-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1311.00 1321.44 <o,f0,female> just(2) for(2) two seconds(2) how these <sil> technologies work because(2) i think it's important to understand it {BREATH} what happens is <sil> every protein in your body is charged {BREATH} so the proteins are(2) <sil> sprayed in <sil> (DavidAgus_2009P-1311.00-1321.44-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1321.67 1329.59 <o,f0,female> the magnet spins them(2) around(2) <sil> and then there's a {COUGH} detector at the(2) end <sil> when(3) it hit that detector <sil> is dependent on(2) the mass and the charge <sil> (DavidAgus_2009P-1321.67-1329.59-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 132.20 139.74 <o,f0,female> does(2) it look abnormal <sil> so that pathologist is just like looking at this plastic bottle <sil> this is a normal cell {SMACK} this is a(2) cancer cell <sil> (DavidAgus_2009P-132.20-139.74-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1330.54 1340.08 <o,f0,female> and(2) so {NOISE} accurately if the magnet is big enough <sil> and(2) your(2) resolution is high enough {BREATH} you can(2) <sil> actually(3) detect all of the proteins in the body <sil> and(2) start to get(2) an {UH} understanding <sil> (DavidAgus_2009P-1330.54-1340.08-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1340.59 1346.45 <o,f0,female> of {UH} the(2) individual <sil> system {BREATH} and so {UH} as a cancer doctor <sil> instead of having {COUGH} paper <sil> (DavidAgus_2009P-1340.59-1346.45-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1346.99 1356.51 <o,f0,female> in my chart in your(2) chart and it being this thick <sil> this is what <sil> data(2) flow is starting to look like in our offices <sil> where that <sil> drop of blood is {COUGH} creating gigabytes of data(2) <sil> (DavidAgus_2009P-1346.99-1356.51-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1369.49 1373.75 <o,f0,female> {UH} without(2) <sil> fundamental <sil> learning {BREATH} so <sil> to(3) conclude {COUGH} <sil> (DavidAgus_2009P-1369.49-1373.75-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 1375.23 1387.84 <o,f0,female> we need to(2) get(2) away from reductionist thinking <sil> we need to start to(2) think differently(2) <sil> and radically <sil> and so i implore everyone here <sil> think differently(2) <sil> come up with <sil> new ideas tell them to me or(2) <sil> anyone else in our field <sil> (DavidAgus_2009P-1375.23-1387.84-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 140.07 146.95 <o,f0,female> that is the state of the(2) art {NOISE} today <sil> in diagnosing cancer <sil> there's no <sil> molecular test (DavidAgus_2009P-140.07-146.95-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 1410.01 1417.90 <o,f0,female> that(2) it's going(2) to be a broad {COUGH} platform of <sil> technologies {SMACK} that will(2) help us move forward <sil> and hopefully help patients in the near term <sil> thank you very much <sil> (DavidAgus_2009P-1410.01-1417.90-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 156.35 165.96 <o,f0,female> you know(2) {SMACK} i know(2) very well <sil> as(3) a cancer doctor <sil> i can't treat advanced cancer {BREATH} so <sil> as(3) an(2) aside {NOISE} i firmly believe <sil> (DavidAgus_2009P-156.35-165.96-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 16.24 27.08 <o,f0,female> i'm a {COUGH} cancer doctor and(2) i walked out of my office {BREATH} and walked by the pharmacy in the hospital {SMACK} three or(2) four years(2) ago {UH} and {NOISE} this was the cover <sil> of fortune magazine sitting in the window of the pharmacy <sil> (DavidAgus_2009P-16.24-27.08-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 166.10 174.37 <o,f0,female> in the field <sil> of <sil> trying to identify cancer {NOISE} early {BREATH} it is the(2) {NOISE} only way <sil> you can(2) start to fight cancer is by catching it early <sil> (DavidAgus_2009P-166.10-174.37-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 175.07 181.93 <o,f0,female> we can {SMACK} prevent most cancers <sil> you know(2) the previous talk alluded to(3) {UH} preventing heart disease we could do the same in cancer <sil> (DavidAgus_2009P-175.07-181.93-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 182.59 189.79 <o,f0,female> co founded a company called navigenics {BREATH} where if you spit into a tube and(2) we can(2) look {UH} look at thirty five or(2) {NOISE} forty <sil> genetic {UH} (DavidAgus_2009P-182.59-189.79-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 190.74 201.56 <o,f0,female> markers for(2) disease {COUGH} all of which are(2) delayable <sil> in many of the(2) cancers {BREATH} you start to(3) identify <sil> what you {UH} could get <sil> and then we can(2) start to work {COUGH} to prevent {COUGH} them(2) <sil> (DavidAgus_2009P-190.74-201.56-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 208.46 218.25 <o,f0,female> <sil> so {UH} the thing about cancer is {NOISE} that {NOISE} it's a disease of the(2) aged(2) <sil> why is it a disease of the(2) aged(2) <sil> because(2) {SMACK} evolution <sil> doesn't(2) care about us {NOISE} after we've had our children <sil> (DavidAgus_2009P-208.46-218.25-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 227.20 236.87 <o,f0,female> <sil> said {NOISE} it doesn't matter anymore {UH} because(2) they've had <sil> their progeny <sil> so <sil> if you look at cancers {NOISE} it is {NOISE} very rare {UH} extremely rare <sil> to have(2) cancer in a child <sil> (DavidAgus_2009P-227.20-236.87-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 238.01 240.25 <o,f0,female> <sil> on the order of thousands(2) of cases(2) a year <sil> (DavidAgus_2009P-238.01-240.25-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 241.05 243.88 <o,f0,female> as(3) {COUGH} one gets {NOISE} older <sil> very very common <sil> (DavidAgus_2009P-241.05-243.88-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 244.93 253.58 <o,f0,female> why(2) is it hard to treat <sil> because(2) it's heterogeneous and that's the <sil> perfect(2) <sil> substrate <sil> for <sil> evolution within the(2) cancer <sil> (DavidAgus_2009P-244.93-253.58-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 253.98 260.38 <o,f0,female> it starts to select out for those <sil> bad {UH} aggressive cells {BREATH} what(2) we call {UH} clonal <sil> selection {SMACK} <sil> (DavidAgus_2009P-253.98-260.38-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 261.31 269.55 <o,f0,female> {UH} but <sil> if we start <sil> to(2) {UH} understand <sil> that cancer {NOISE} isn't(2) just <sil> a molecular defect(2) it's something more {COUGH} <sil> (DavidAgus_2009P-261.31-269.55-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 270.34 279.14 <o,f0,female> get <sil> to new ways of treating it {UH} as i'll show you {BREATH} so one(2) of the fundamental problems we have(2) in cancer {SMACK} is that right now we describe it <sil> by a number of adjectives symptoms {BREATH} (DavidAgus_2009P-270.34-279.14-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 279.83 287.95 <o,f0,female> tired i'm <sil> bloated i have(2) <sil> pain {NOISE} etc {BREATH} you then have(2) some {COUGH} anatomic descriptions you get that cat scan there's a {SMACK} three centimeter mass in the liver <sil> (DavidAgus_2009P-279.83-287.95-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 288.42 296.35 <o,f0,female> <sil> you then have(2) some {UH} body {NOISE} part descriptions {SMACK} it's in the liver {NOISE} in the breast in the prostate {SMACK} and <sil> that's about it <sil> so {UH} (DavidAgus_2009P-288.42-296.35-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 296.70 304.79 <o,f0,female> our {UH} dictionary for(2) describing cancer {COUGH} is <sil> very {NOISE} very poor {BREATH} it's <sil> basically symptoms it's manifestations of a disease <sil> (DavidAgus_2009P-296.70-304.79-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 305.23 315.78 <o,f0,female> what's(2) exciting is that over the last(2) two or(2) three years the(2) government has spent {BREATH} four hundred(3) million dollars <sil> and they've {UH} allocated another billion dollars {BREATH} to what(2) we call the(2) cancer genome atlas project <sil> (DavidAgus_2009P-305.23-315.78-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 330.90 340.55 <o,f0,female> <sil> hasn't changed in {NOISE} over {UM} one(2) hundred and fifty years <sil> it is {NOISE} absolutely archaic {COUGH} that we call {NOISE} cancer by prostate {BREATH} by {UH} breast <sil> by {UH} (DavidAgus_2009P-330.90-340.55-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 341.52 353.40 <o,f0,female> {NOISE} muscle <sil> it makes {SMACK} no sense <sil> if you think about it {BREATH} so {UH} obviously {NOISE} the technology is here today and over the next several years(2) {NOISE} that will(2) change {BREATH} you will no longer go to a breast cancer clinic {BREATH} <sil> (DavidAgus_2009P-341.52-353.40-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 353.77 367.62 <o,f0,female> you will go to a her two {NOISE} amplified {UH} clinic {SMACK} or an(2) egfr {UH} activated(2) clinic {BREATH} and they will go to some of the pathogenic lesions that were(2) involved <sil> in causing this {SMACK} individual cancer {BREATH} so hopefully we will go from being the(2) {NOISE} art {NOISE} of medicine <sil> (DavidAgus_2009P-353.77-367.62-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 382.55 394.83 <o,f0,female> <sil> when(3) one is exposed to(3) <sil> h one n one <sil> you take tamiflu and you can(2) remarkably {SMACK} decrease(2) the severity of symptoms and <sil> prevent {SMACK} many of the manifestations of the disease why {BREATH} because(2) we know(2) what you {NOISE} <sil> (DavidAgus_2009P-382.55-394.83-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 38.76 49.77 <o,f0,female> where(2) his(2) parents drove him from new york city {SMACK} to(2) {UH} upstate new(2) york <sil> to get an {UH} experimental(2) therapy for(2) at the time hodgkin 's(3) disease which saved his life {SMACK} he makes {NOISE} remarkable points here <sil> (DavidAgus_2009P-38.76-49.77-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 395.39 408.10 <o,f0,female> and(2) we know(2) how to {NOISE} treat it <sil> although we can't make vaccine(2) in this country but that's a different story {COUGH} the {UM} cancer genome atlas {SMACK} is coming out now {UH} the first cancer was {NOISE} done which was brain cancer <sil> (DavidAgus_2009P-395.39-408.10-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 408.63 415.56 <o,f0,female> in the {UH} next(2) month {UH} the(2) end of december <sil> you'll see ovarian {COUGH} cancer <sil> and then lung {COUGH} cancer will come several months after <sil> <sil> (DavidAgus_2009P-408.63-415.56-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 416.25 425.43 <o,f0,female> {NOISE} there's also a field {COUGH} of proteomics {SMACK} that i'll {UH} talk about in a few minutes which i think is going to be the next level {SMACK} in terms of <sil> understanding and classifying <sil> disease {BREATH} (DavidAgus_2009P-416.25-425.43-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 426.11 434.50 <o,f0,female> but remember <sil> i'm(2) not pushing {NOISE} genomics {SMACK} proteomics to be a reductionist <sil> i'm doing it so we can(2) identify what(2) we're up against <sil> (DavidAgus_2009P-426.11-434.50-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 444.77 456.20 <o,f0,female> most of the dollars in the last(2) {BREATH} two years(2) of a person 's(3) life {BREATH} we spend very little {NOISE} if <sil> any dollars in terms of identifying what we're up against {BREATH} if you could start <sil> to move that (DavidAgus_2009P-444.77-456.20-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 456.58 465.23 <o,f0,female> to identify what(2) you're up against you're going to do things a {COUGH} hell of a lot {SMACK} better {BREATH} if we could even take it one(2) step further <sil> and <sil> prevent <sil> disease <sil> we can take it (DavidAgus_2009P-456.58-465.23-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 475.14 482.95 <o,f0,female> {NOISE} and(2) i'm here to tell you it's wrong <sil> so the website of the national cancer institute says {COUGH} that cancer is a genetic <sil> disease <sil> (DavidAgus_2009P-475.14-482.95-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 483.93 493.14 <o,f0,female> the website says {UH} if you look there's an individual mutation <sil> and maybe a second(2) <sil> and maybe a third <sil> and that {NOISE} is cancer <sil> but as(3) a <sil> cancer {UH} (DavidAgus_2009P-483.93-493.14-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 493.89 505.94 <o,f0,female> this is what i see <sil> this isn't a genetic <sil> disease <sil> so {UH} there you see <sil> it's a liver <sil> with(2) colon cancer in it {BREATH} and you see into the microscope a lymph <sil> node where(2) cancer has invaded(2) {BREATH} you see a(2) cat scan <sil> (DavidAgus_2009P-493.89-505.94-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 50.22 57.90 <o,f0,female> <sil> and the point of the(2) article was {BREATH} that {COUGH} we have gotten reductionist {SMACK} in our <sil> view <sil> of biology <sil> in our view of cancer <sil> (DavidAgus_2009P-50.22-57.90-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 506.52 514.37 <o,f0,female> where(2) <sil> cancer is in the liver {BREATH} cancer {NOISE} is an interaction {COUGH} of a cell <sil> that no longer <sil> is <sil> under(2) growth control (DavidAgus_2009P-506.52-514.37-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 514.60 522.06 <o,f0,female> with the(2) environment <sil> it's not in the(2) abstract <sil> it's the interaction with(2) the(2) environment {BREATH} it's what(2) we call a system <sil> (DavidAgus_2009P-514.60-522.06-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 523.42 533.52 <o,f0,female> the <sil> goal {NOISE} of me as a cancer doctor is not to {UH} understand cancer <sil> and i think that's <sil> been(2) the fundamental problem over the last(2) five decades {BREATH} is that we have strived {UH} to(2) {UH} understand cancer <sil> (DavidAgus_2009P-523.42-533.52-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 534.00 541.10 <o,f0,female> the(2) goal is to control cancer <sil> and(2) <sil> that is a very <sil> different optimization scheme <sil> a very <sil> different strategy for(2) all of us <sil> (DavidAgus_2009P-534.00-541.10-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 541.43 549.84 <o,f0,female> i got up at the american(2) {NOISE} association(2) of cancer research one(2) of the <sil> big {NOISE} cancer research meetings with twenty thousand(2) people there {BREATH} and <sil> i said we've made a mistake <sil> (DavidAgus_2009P-541.43-549.84-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 550.70 559.98 <o,f0,female> all made a mistake myself included {BREATH} by focusing(2) down by <sil> being a reductionist we need to take a(2) step back and believe it or(2) not there were(2) hisses in the(2) audience(2) <sil> people got upset <sil> (DavidAgus_2009P-550.70-559.98-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 560.34 571.37 <o,f0,female> <sil> but this is the(2) <sil> only way we're going(2) <sil> to go forward {UH} you {BREATH} know(2) i was very fortunate to meet <sil> danny hillis <sil> a few years(2) ago {BREATH} we were(2) pushed together <sil> and {COUGH} neither(2) one of us really wanted to meet the(2) other <sil> (DavidAgus_2009P-560.34-571.37-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 571.65 584.36 <o,f0,female> i said do {SMACK} i really want to meet a(2) {NOISE} guy from <sil> disney who designed computers {BREATH} and he was saying does(2) he really want to meet another doctor {SMACK} but <sil> people prevailed on us and we got together and it's been(2) transformative in what i do <sil> absolutely {NOISE} (DavidAgus_2009P-571.65-584.36-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 58.22 66.16 <o,f0,female> for(2) the last fifty years <sil> we have focused(2) <sil> on(2) {UH} treating the(2) individual gene in understanding cancer <sil> not in controlling cancer <sil> (DavidAgus_2009P-58.22-66.16-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 586.42 593.20 <o,f0,female> we have <sil> designed and we have worked on(2) <sil> the modeling <sil> and much of these ideas {SMACK} came <sil> from <sil> danny {SMACK} and from(2) his team <sil> (DavidAgus_2009P-586.42-593.20-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 593.48 601.22 <o,f0,female> the modeling(2) of cancer in the body as(2) {NOISE} complex(2) system {BREATH} and i'll show you some data(2) there {COUGH} where i really(2) think {SMACK} it can(2) make a difference <sil> and a new way to (DavidAgus_2009P-593.48-601.22-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 602.62 612.32 <o,f0,female> the(2) key is {BREATH} when you look at these variables {SMACK} and you look at this data(2) <sil> you have(2) to(2) {UH} understand <sil> the data(2) inputs <sil> you know(2) if i measured your(2) temperature <sil> (DavidAgus_2009P-602.62-612.32-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 612.90 621.41 <o,f0,female> <sil> over <sil> thirty days <sil> and i asked what(2) was the(2) average temperature {BREATH} and {NOISE} it came back at ninety eight point seven {BREATH} i would say great <sil> but {UH} if (DavidAgus_2009P-612.90-621.41-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 621.59 629.13 <o,f0,female> during one of those days your(2) temperature spiked to(3) one(2) hundred(3) and(2) two <sil> for six hours and you took tylenol and(2) got <sil> better etc {BREATH} i would <sil> totally miss {SMACK} <sil> (DavidAgus_2009P-621.59-629.13-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 629.63 640.49 <o,f0,female> so <sil> one {UH} of {NOISE} the fundamental problems in medicine {NOISE} is that you and(2) i and all of us {BREATH} we go to our doctor once a year <sil> we have(2) {SMACK} discrete {SMACK} data(2) elements {BREATH} we don't have(2) a time function on(2) them <sil> (DavidAgus_2009P-629.63-640.49-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 641.28 651.45 <o,f0,female> earlier it was referred to(3) this direct life {COUGH} device {SMACK} you know(2) {UH} i've {COUGH} been(2) using it for(2) two and(2) a half months <sil> it's a staggering device {BREATH} not <sil> because(2) it tells me how many kilocalories {UH} i do every day <sil> (DavidAgus_2009P-641.28-651.45-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 651.74 660.26 <o,f0,female> but because(2) it looks {SMACK} over <sil> twenty four hours what i've done in a day {BREATH} and i didn't realize(2) that for three hours i'm sitting at my desk {SMACK} and i'm not moving at all <sil> (DavidAgus_2009P-651.74-660.26-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 660.73 667.66 <o,f0,female> and(2) {SMACK} a lot of the functions in the data(2) <sil> that we have(2) as input systems here <sil> are really(2) {UH} different than we (DavidAgus_2009P-660.73-667.66-F0_F-S113)
DavidAgus_2009P 1 DavidAgus_2009P 66.48 80.19 <o,f0,female> so this is an(2) astounding {SMACK} table {BREATH} and this is something that sobers {UH} us in our field everyday {BREATH} in that obviously we've made {NOISE} remarkable impacts(2) on cardiovascular disease but look at cancer <sil> the(2) <sil> death rate in <sil> cancer in over fifty years <sil> (DavidAgus_2009P-66.48-80.19-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 679.82 688.91 <o,f0,female> so the states {COUGH} are equivalent classes of history {BREATH} and the(2) cancer patient the(2) input is the(2) environment <sil> the <sil> diet <sil> the <sil> treatment <sil> the genetic mutations <sil> (DavidAgus_2009P-679.82-688.91-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 689.34 698.44 <o,f0,female> the(2) output {COUGH} are our symptoms <sil> do we have(2) <sil> pain {NOISE} is the(2) cancer growing <sil> do we feel bloated {NOISE} etc {BREATH} most of that state {SMACK} <sil> (DavidAgus_2009P-689.34-698.44-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 699.21 709.94 <o,f0,female> is hidden <sil> so what(2) we do in our field <sil> is we change and(2) input <sil> we give aggressive chemotherapy {BREATH} and we say {SMACK} did that output <sil> get {COUGH} better <sil> did that {COUGH} pain improve <sil> etc <sil> (DavidAgus_2009P-699.21-709.94-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 710.82 719.86 <o,f0,female> and(2) so {BREATH} the problem is that it's not just one system <sil> it's {NOISE} multiple systems {NOISE} on multiple scales {BREATH} it's a system <sil> of systems <sil> (DavidAgus_2009P-710.82-719.86-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 720.26 732.08 <o,f0,female> and so when you start to look at emergent systems {BREATH} you can(2) look at a neuron under(2) a microscope <sil> a neuron under(2) the microscope is very {NOISE} elegant with <sil> little things sticking out and little things over here {BREATH} but when(3) you start to put them together <sil> (DavidAgus_2009P-720.26-732.08-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 732.54 739.15 <o,f0,female> in a complex(2) system {BREATH} and(2) you start to see that {COUGH} it becomes a brain <sil> and that {UH} brain can create intelligence <sil> (DavidAgus_2009P-732.54-739.15-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 739.78 746.72 <o,f0,female> what(2) we're talking about in the body <sil> and(2) cancer is starting to model it like a complex(2) system {BREATH} well {UH} the bad news is that {COUGH} these (DavidAgus_2009P-739.78-746.72-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 747.20 755.72 <o,f0,female> robust and robust is a key word emergent systems {COUGH} are very hard to understand <sil> in detail(2) {BREATH} the good(2) news is {SMACK} you can(2) manipulate them <sil> (DavidAgus_2009P-747.20-755.72-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 756.32 764.76 <o,f0,female> you can(2) try to(2) control them <sil> without(2) <sil> that fundamental understanding of every(2) component {BREATH} one of the most(2) fundamental clinical(2) trials(2) in cancer <sil> (DavidAgus_2009P-756.32-764.76-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 765.03 773.79 <o,f0,female> came out in february(2) in the the new(2) england journal of medicine {BREATH} where they took women who were(2) pre menopausal <sil> with {SMACK} breast cancer so {UH} about <sil> the worst kind of <sil> breast cancer you can get (DavidAgus_2009P-765.03-773.79-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 775.23 788.13 <o,f0,female> gotten(2) their chemotherapy {NOISE} and then they randomized them {BREATH} where half {BREATH} got <sil> placebo {SMACK} and half got a(2) {BREATH} drug called zoledronic acid that {COUGH} builds bone <sil> it's used to treat osteoporosis and they got that twice a year <sil> (DavidAgus_2009P-775.23-788.13-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 801.43 808.17 <o,f0,female> reduced(3) {NOISE} occurrence of cancer by a {COUGH} drug that(2) doesn't even touch the cancer {BREATH} so the notion you change the soil <sil> (DavidAgus_2009P-801.43-808.17-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 809.10 823.26 <o,f0,female> the seed doesn't grow as well {BREATH} you change that system <sil> and you could have a marked effect(2) on the(2) cancer {BREATH} nobody has ever shown and this will be shocking nobody has {NOISE} ever shown {BREATH} that most(2) chemotherapy actually(4) <sil> touches a cancer cell <sil> (DavidAgus_2009P-809.10-823.26-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 81.11 95.10 <o,f0,female> <sil> changed <sil> we've made small wins in diseases like chronic {COUGH} myelogenous leukemia where(2) we have a pill that can(2) put one(2) hundred percent of {BREATH} people in remission {BREATH} but {NOISE} in general <sil> we haven't made an(2) impact <sil> at {NOISE} all {NOISE} in the war on(2) cancer {SMACK} <sil> (DavidAgus_2009P-81.11-95.10-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 823.89 837.48 <o,f0,female> it's never been(2) shown {BREATH} there's {SMACK} all these <sil> elegant work in the tissue culture dishes(2) {SMACK} that if you give {NOISE} this {NOISE} cancer drug you can <sil> do this effect to the cell {BREATH} but the {COUGH} doses(2) <sil> in those dishes(2) <sil> are nowhere near {COUGH} the <sil> doses that happen in the body <sil> (DavidAgus_2009P-823.89-837.48-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 838.41 847.08 <o,f0,female> if i {COUGH} give a woman with(2) breast cancer a drug called taxol <sil> every three weeks which(2) is the standard {BREATH} about forty percent of women with metastatic cancer have(2) a great {NOISE} response (DavidAgus_2009P-838.41-847.08-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 854.79 866.67 <o,f0,female> they then recur <sil> i give them(2) that same drug {UH} every(2) week <sil> another thirty percent will respond <sil> they then recur {UH} i give them that same drug over ninety six hrs by continuous infusion {SMACK} <sil> (DavidAgus_2009P-854.79-866.67-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 867.13 874.55 <o,f0,female> another twenty or(2) thirty percent will respond {BREATH} so you <sil> can't <sil> tell me it's working by the same mechanism in all three size <sil> it's not <sil> (DavidAgus_2009P-867.13-874.55-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 874.84 882.58 <o,f0,female> we have no idea the mechanism {BREATH} so the(2) idea that chemotherapy <sil> may {SMACK} just {COUGH} be <sil> disrupting that {UH} complex(2) system <sil> (DavidAgus_2009P-874.84-882.58-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 883.08 892.57 <o,f0,female> just(2) like {BREATH} building bone <sil> disrupted that system and reduced(2) recurrence {BREATH} chemotherapy may work by that same <sil> exact <sil> way {BREATH} the wild {COUGH} thing about that trial {UH} (DavidAgus_2009P-883.08-892.57-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 893.38 899.26 <o,f0,female> <sil> {UH} also {UH} was {UH} it {NOISE} reduced <sil> new <sil> primaries so new <sil> cancers {SMACK} by thirty percent also {UH} <sil> (DavidAgus_2009P-893.38-899.26-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 902.37 902.54 <o,f0,male> <sil> so <sil> (DavidAgus_2009P-902.37-902.54-F0_M-S151)
DavidAgus_2009P 1 DavidAgus_2009P 903.20 917.20 <o,f0,female> the problem is <sil> yours and mine {COUGH} all of our systems <sil> are changing <sil> they're dynamic {BREATH} i mean {NOISE} this is a scary slide {UH} not to(2) take an aside {BREATH} but it looks at obesity(2) <sil> in the world and i'm sorry if you {UH} can't read(2) the numbers their {SMACK} kind of small <sil> (DavidAgus_2009P-903.20-917.20-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 917.65 925.64 <o,f0,female> but <sil> if you start to look at it {NOISE} that red <sil> that dark color(2) there {BREATH} more than seventy five percent of the population of those countries <sil> are obese(2) <sil> (DavidAgus_2009P-917.65-925.64-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 927.82 940.94 <o,f0,female> <sil> look a(2) <sil> decade ago look two decades ago <sil> markedly(2) different {BREATH} so our systems today <sil> are dramatically(2) different <sil> than a {NOISE} decade {NOISE} or two <sil> ago {BREATH} so the diseases(2) we have(2) today <sil> (DavidAgus_2009P-927.82-940.94-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 941.71 951.59 <o,f0,female> {NOISE} which(2) <sil> reflect {SMACK} patterns in the system over the last several decades are(2) going(2) to change {COUGH} dramatically(2) <sil> over the next(2) decade <sil> or so <sil> based on <sil> things like <sil> this <sil> (DavidAgus_2009P-941.71-951.59-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 953.45 956.00 <o,f0,male> <sil> so {COUGH} this {COUGH} picture {COUGH} (DavidAgus_2009P-953.45-956.00-F0_M-S151)
DavidAgus_2009P 1 DavidAgus_2009P 956.95 961.25 <o,f0,female> although it is <sil> beautiful {NOISE} is <sil> a(2) <sil> forty {COUGH} gigabyte {UH} (DavidAgus_2009P-956.95-961.25-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 96.06 103.22 <o,f0,female> so what i'm(2) going to tell you today {NOISE} is a little bit {NOISE} of {UH} why i {COUGH} think that's the case {SMACK} and then {COUGH} go out of my comfort zone <sil> (DavidAgus_2009P-96.06-103.22-F0_F-S10)
DavidAgus_2009P 1 DavidAgus_2009P 962.10 976.03 <o,f0,female> <sil> <sil> picture {NOISE} of the {NOISE} whole proteome <sil> so this is a drop of blood that(2) has gone through a superconducting magnet <sil> and {UM} we're {NOISE} able to get resolution {NOISE} where we can(2) start to see {NOISE} all of the proteins in the body {UM} we can(2) start to see that system <sil> (DavidAgus_2009P-962.10-976.03-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 976.63 987.63 <o,f0,female> each of the red <sil> dots {NOISE} are(2) where a protein has actually(4) been(2) identified {BREATH} the power of these magnets the power of what(2) we can do here is that we can(2) see an <sil> individual neutron <sil> with(2) this technology <sil> <sil> (DavidAgus_2009P-976.63-987.63-F0_F-S104)
DavidAgus_2009P 1 DavidAgus_2009P 988.41 996.27 <o,f0,female> {NOISE} this is {UH} stuff {NOISE} we're(3) doing with(2) {COUGH} danny hillis {NOISE} and a group called applied proteomics {BREATH} where(2) we can(2) start {NOISE} see <sil> individual neutron {UH} differences {BREATH} (DavidAgus_2009P-988.41-996.27-F0_F-S104)
